We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-2.01%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$98.4B
AUM Growth
-$2.76B
Cap. Flow
-$1.74B
Cap. Flow %
-1.77%
Top 10 Hldgs %
21.87%
Holding
3,216
New
68
Increased
954
Reduced
1,923
Closed
84

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$106M
2
CRH icon
CRH
CRH
+$105M
3
AMZN icon
Amazon
AMZN
+$102M
4
AAPL icon
Apple
AAPL
+$98.1M
5
SLV icon
iShares Silver Trust
SLV
+$83.3M

Sector Composition

Rank Sector Weight
1 Technology 25.18%
2 Healthcare 15%
3 Financials 13.74%
4 Consumer Discretionary 9.98%
5 Industrials 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAFT icon
1901
Safety Insurance
SAFT
$1.52B
$1.67M ﹤0.01%
24,418
-808
-3% -$56.2K
SII
1902
Sprott
SII
$2.98B
$1.66M ﹤0.01%
40,157
-1,179
-3% -$38.8K
CAMT icon
1903
Camtek
CAMT
$7.19B
$1.66M ﹤0.01%
26,682
+332
+1% +$16.4K
CRDO icon
1904
Credo Technology Group
CRDO
$45B
$1.66M ﹤0.01%
108,878
+21,295
+24% +$336K
VIR icon
1905
Vir Biotechnology
VIR
$1.51B
$1.66M ﹤0.01%
177,193
+32,425
+22% +$462K
HLIO icon
1906
Helios Technologies
HLIO
$2.72B
$1.66M ﹤0.01%
29,888
-1,516
-5% -$90.1K
DDS icon
1907
Dillards
DDS
$9.44B
$1.66M ﹤0.01%
5,003
-282
-5% -$93.1K
CARG icon
1908
CarGurus
CARG
$3.61B
$1.65M ﹤0.01%
94,257
-9,913
-10% -$196K
TRMK icon
1909
Trustmark
TRMK
$2.77B
$1.65M ﹤0.01%
75,858
-2,360
-3% -$54.8K
MD icon
1910
Pediatrix Medical
MD
$2.22B
$1.65M ﹤0.01%
129,507
-2,242
-2% -$30.8K
NWBI icon
1911
Northwest Bancshares
NWBI
$2.29B
$1.64M ﹤0.01%
160,732
-4,511
-3% -$50.3K
OPEN icon
1912
Opendoor
OPEN
$3.48B
$1.64M ﹤0.01%
643,421
-103,375
-14% -$373K
TNC icon
1913
Tennant Co
TNC
$1.31B
$1.64M ﹤0.01%
22,099
-1,054
-5% -$84.1K
PCRX icon
1914
Pacira BioSciences
PCRX
$1.01B
$1.64M ﹤0.01%
53,394
-2,455
-4% -$88.5K
TDW icon
1915
Tidewater
TDW
$4.06B
$1.64M ﹤0.01%
23,022
-10,036
-30% -$634K
BCRX icon
1916
BioCryst Pharmaceuticals
BCRX
$2.38B
$1.64M ﹤0.01%
231,051
-50,966
-18% -$366K
STM icon
1917
STMicroelectronics
STM
$49.7B
$1.63M ﹤0.01%
37,834
+22,344
+144% +$1.07M
CWEN.A
1918
DELISTED
Clearway Energy Class A
CWEN.A
$1.63M ﹤0.01%
81,873
+466
+0.6% +$11.2K
PTCT icon
1919
PTC Therapeutics
PTCT
$5.98B
$1.63M ﹤0.01%
72,694
-16,831
-19% -$626K
NIC icon
1920
Nicolet Bankshares
NIC
$3.61B
$1.63M ﹤0.01%
21,015
-1,033
-5% -$77.8K
AMSF icon
1921
AMERISAFE
AMSF
$546M
$1.62M ﹤0.01%
32,447
-1,030
-3% -$54K
PDFS icon
1922
PDF Solutions
PDFS
$2.08B
$1.61M ﹤0.01%
49,836
-1,614
-3% -$61.8K
RVNC
1923
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.61M ﹤0.01%
140,615
-1,573
-1% -$30.2K
CENX icon
1924
Century Aluminum
CENX
$5.03B
$1.61M ﹤0.01%
224,202
+24,418
+12% +$197K
NNI icon
1925
Nelnet
NNI
$4.64B
$1.61M ﹤0.01%
18,004
-752
-4% -$71K

Similar funds

Credit Suisse's Q3 2023 Portfolio in Review

As of Q3 2023, Credit Suisse held 3,216 positions worth $98.4B, down 2.7% from $101B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.7%. Credit Suisse opened 68 new positions and exited 84, leaving the 3,216-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q3 2023 buy was CRH: 1,849,255 shares worth $101M.
  • Credit Suisse added most to Alibaba in Q3 2023, an estimated $106M increase.
  • Credit Suisse's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $321M.
  • Credit Suisse fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $24.8M.
  • Credit Suisse's ten largest holdings make up 22% of its $98.4B portfolio in Q3 2023.
  • Credit Suisse opened 68 new positions and closed 84 in Q3 2023.
  • Credit Suisse's portfolio value fell 2.7% quarter-over-quarter to $98.4B.

Based on Credit Suisse's 13F filing for Q3 2023, filed 13 Nov 2023.